Effectiveness of biological therapy in severe asthma: a retrospective real-world study.

Croat Med J · 2025 · PMC11947975 · PMID 40047156

Europe PMC

hedged sentence

0.0250

closest p · 0.5× alpha

0.0250

boldest claim

The sentences

an increasing trendP = 0.025actually significant

FeNO showed two different patterns: an increasing trend in the benralizumab and omalizumab groups and a decline in the mepolizumab and reslizumab groups ( P = 0.025; Figure 3C ).

also in 37,718 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.